Form 4: Outset Medical GC Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


Outset Medical's General Counsel, John L. Brottem, sold 224 shares of common stock to cover tax withholding obligations related to vested performance share units.

Summary

  • John L. Brottem, General Counsel of Outset Medical, Inc. (OM), reported a transaction involving the company's common stock.
  • On January 7, 2026, Brottem disposed of 224 shares of common stock at a price of $4.27 per share.
  • The sale was a 'sell to cover' transaction, specifically to satisfy tax withholding obligations associated with 447 shares of Common Stock underlying Performance Share Units (PSUs).
  • These PSUs were earned based on performance criteria achieved as of December 31, 2024, or January 6, 2025, and certified by the Compensation Committee on January 17, 2025.
  • The PSUs vested and were released on January 6, 2025.
  • Following this transaction, John L. Brottem beneficially owns 46,271 shares of Outset Medical common stock directly.
  • The reporting person explicitly stated that this sale does not represent a discretionary trade.

Sentiment

Score: 5

Explanation: The transaction is a non-discretionary 'sell to cover' for tax purposes, which is a routine event for executives receiving equity compensation and does not reflect a positive or negative outlook on the company's performance or stock.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

  • The sale was made to satisfy tax withholding obligations through a 'sell to cover' transaction and does not represent a discretionary trade by the reporting person.

Industry Context

This is a routine insider transaction filing (Form 4) detailing a 'sell to cover' event for tax purposes, which is common for executives receiving equity compensation. It does not provide information relevant to broader industry trends or competitive positioning.

Key Dates

DateDescription
12/31/2024Performance criteria achievement date for Performance Share Units (PSUs).
01/06/2025Performance criteria achievement date for Performance Share Units (PSUs), and date PSUs vested and were released.
01/17/2025Compensation Committee certified the achievement of applicable performance criteria for PSUs.
01/07/2026Transaction date for the sale of 224 shares of common stock.
01/08/2026Signature date of the reporting person on the Form 4 filing.

Keywords

Outset Medical, OM, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Performance Share Units, John L. Brottem, General Counsel

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.